Sub-Total: $0.00
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Related products
-
Dry Eye Disease: Current and Emerging Novel Tear Stimulating Therapies for Improved Outcomes
Read more -
New Paradigms for Treatment and Management of Retinal Vein Occlusion (RVO)
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more -
New Paradigms in the Biological Therapies for Atopic Dermatitis
Read more
